5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease-Reference-Cited by-同舟云学术

5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease

Published:2013-11-22 Issue:3 Volume:92 Page:347-358
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:Journal of Neuroscience Research

Author:

Aureli Cristina¹,Cassano Tommaso²,Masci Alessandra¹,Francioso Antonio¹,Martire Sara¹,Cocciolo Annalisa¹,Chichiarelli Silvia¹,Romano Adele³,Gaetani Silvana³,Mancini Patrizia⁴,Fontana Mario¹,d'Erme Maria¹⁵,Mosca Luciana¹

Affiliation:

1. Department of Biochemical Sciences; “Sapienza” University; Roma Italy

2. Department of Clinical and Experimental Medicine; University of Foggia; Italy

3. Department of Physiology and Pharmacology V. Erspamer; “Sapienza” University; Roma Italy

4. Department of Experimental Medicine; “Sapienza” University; Roma Italy

5. Pasteur Institute; Fondazione Cenci-Bolognetti; Roma Italy

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jnr.23318/fullpdf

Reference77 articles.

1. Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein;Akazawa;Free Radic Res,2010

2. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease;Alam;J Neurochem,1997

3. Redox-based endoplasmic reticulum dysfunction in neurological diseases;Banhegyi;J Neurochem,2008

4. Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease;Bellucci;J Neurochem,2011

5. The 6-hydroxydopamine model: news from the past;Blandini;Parkinsonism Rel Disord,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neuroprotective effect of vitamin D in Parkinson's disease: association or causation;Nutritional Neuroscience;2023-09-20

2. Ketone Bodies and Brain Metabolism: New Insights and Perspectives for Neurological Diseases;The Journal of Neuropsychiatry and Clinical Neurosciences;2023-04

3. Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease;ACS Chemical Neuroscience;2023-03-29

4. The Role of Ketogenic Diet in the Treatment of Neurological Diseases;Nutrients;2022-11-24

5. ERp57 chaperon protein protects neuronal cells from Aβ‐induced toxicity;Journal of Neurochemistry;2022-07-08